Holen Sie sich die Stockscreener-App
38.94
1.34%
-0.53
Schlusskurs vom Vortag:
$39.47
Offen:
$38.49
24-Stunden-Volumen:
2.66M
Relative Volume:
1.79
Marktkapitalisierung:
$3.07B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+24.93%
1M Leistung:
-17.38%
6M Leistung:
-32.92%
1J Leistung:
+0.00%
1-Tages-Spanne:
$38.49
$40.87
1-Wochen-Bereich:
$30.08
$40.99
52-Wochen-Spanne:
$30.08
$62.18
Hinge Health Inc Stock (HNGE) Company Profile
Firmenname
Hinge Health Inc
Sektor
Branche
Telefon
415-689-8429
Adresse
455 MARKET STREET, SAN FRANCISCO
Compare HNGE vs VEEV, TEM, BTSG, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HNGE
Hinge Health Inc
|
38.94 | 3.11B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
174.11 | 28.27B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.95 | 9.03B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
38.86 | 6.82B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
73.88 | 6.25B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
25.02 | 4.56B | 550.17M | 201.35M | 232.07M | 1.00 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Wells Fargo | Overweight |
| 2025-09-05 | Eingeleitet | Robert W. Baird | Neutral |
| 2025-07-14 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-06-16 | Eingeleitet | Barclays | Overweight |
| 2025-06-16 | Eingeleitet | BofA Securities | Buy |
| 2025-06-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-06-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-06-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-06-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-06-16 | Eingeleitet | Needham | Buy |
| 2025-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2025-06-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-06-16 | Eingeleitet | Raymond James | Outperform |
| 2025-06-16 | Eingeleitet | Stifel | Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-16 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Hinge Health Inc Aktie (HNGE) Neueste Nachrichten
Hinge Health (HNGE) Q4 2025 Earnings Transcript - AOL.com
Hinge Health (HNGE) Climbs 17% on Revenue Jump, Double-Digit Growth Hopes - Bitget
Hinge Health Stock (+17%): Earnings Beat & AI Narrative Ignite Rally - Trefis
10 Stocks Turning Heads With Double-Digit Returns - Insider Monkey
Hinge Health (HNGE) Revenue Growth And Q4 Profit Test Bullish Earnings Narratives - Sahm
Needham reiterates Buy rating on Hinge Health stock, citing strong FY25 finish By Investing.com - Investing.com South Africa
Hinge Health stock price target lowered to $50 by RBC Capital By Investing.com - Investing.com Canada
HNGE Receives Reiteration of Market Outperform Rating by Citizen - GuruFocus
Barclays lowers Hinge Health stock price target to $52 from $60 By Investing.com - Investing.com Canada
Citizens reiterates Market Outperform rating on Hinge Health stock By Investing.com - Investing.com Canada
Why Hinge Health Stock Is Dropping Despite a Beat - TipRanks
Hinge Health Growth Story Weighs AI Scale Against Valuation Upside - Yahoo Finance
Hinge Health (NYSE:HNGE) Digital Care Updates on NYSE Composite - Kalkine Media
Hinge Health (NYSE:HNGE) Shares Gap UpHere's What Happened - MarketBeat
Why Hinge Health Stock Popped on Wednesday - Yahoo Finance
Truist Securities reiterates Buy rating on Hinge Health stock with $63 target By Investing.com - Investing.com South Africa
Hinge Health (NYSE:HNGE) Earns Market Outperform Rating from Citizens Jmp - MarketBeat
Hinge Health stock price target lowered to $50 by RBC Capital - Investing.com Nigeria
Why Hinge Health Stock Popped on Wednesday - The Motley Fool
Truist Securities reiterates Buy rating on Hinge Health stock with $63 target - Investing.com
Hinge Health (NYSE:HNGE) Price Target Cut to $52.00 by Analysts at Barclays - MarketBeat
Barclays lowers Hinge Health stock price target to $52 from $60 - Investing.com India
RBC Cuts Price Target on Hinge Health to $50 From $60, Keeps Outperform Rating - marketscreener.com
Citizens reiterates Market Outperform rating on Hinge Health stock - Investing.com
Needham reiterates Buy rating on Hinge Health stock, citing strong FY25 finish - Investing.com Nigeria
Needham & Company LLC Reiterates "Buy" Rating for Hinge Health (NYSE:HNGE) - MarketBeat
Hinge Health Inc (HNGE) PT Lowered to $50 at RBC Capital - StreetInsider
HNGE: Today's Analyst Ratings and Price Target Update | HNGE Sto - GuruFocus
Why Is Hinge Health Stock Soaring Wednesday? - Benzinga
Breaking Down Hinge Health: 7 Analysts Share Their Views - Benzinga
How AI investments are driving Hinge Health’s growth - Modern Healthcare News
Hinge Health outlines 25% revenue growth target for 2026 while expanding AI-driven care - MSN
Hinge Health Q4 Adjusted Earnings, Revenue Rise; Shares Jump Pre-Bell - marketscreener.com
Hinge Health Q4 Earnings Call Highlights - MarketBeat
Hinge Health Q4 2025 Earnings Call Transcript - MarketBeat
Hinge Health Reports Strong Q4 2025 Earnings with 46% Revenue Growth - Intellectia AI
Hinge Health Q4 2025 slides: 46% revenue growth, margins expand amid AI push - Investing.com Nigeria
Hinge Health reports fourth quarter and full year 2025 financial results - The National Law Review
Hinge Health reports Q4 EPS 49c, consensus 43c - TipRanks
Earnings call transcript: Hinge Health Q4 2025 delivers strong earnings beat By Investing.com - Investing.com South Africa
HINGE HEALTH INC-A (NYSE:HNGE) Crushes Q4 Estimates and Provides Strong 2026 Guidance - ChartMill
Earnings call transcript: Hinge Health Q4 2025 delivers strong earnings beat - Investing.com
Hinge Health (NYSE:HNGE) Posts Quarterly Earnings Results - MarketBeat
Hinge Health sees Q1 revenue $171M-$173M, consensus $159.67M - TipRanks
Hinge Health Q4 Adjusted Earnings, Revenue Rise; Shares Up After Hours - marketscreener.com
Why Hinge Health, Inc. Class A Shares Are Sinking - TipRanks
Hinge Health soars as Q4 earnings triple estimates, outlook tops consensus - Investing.com India
(HNGE) Hinge Health Expects Full Year 2026 Revenue Range $732M$742M, vs. FactSet Est of $702.9M - marketscreener.com
Hinge Health Posts Record 2025 Results With Strong Profitability - TipRanks
Finanzdaten der Hinge Health Inc-Aktie (HNGE)
Es liegen keine Finanzdaten für Hinge Health Inc (HNGE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
4.14%
8.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):